Akio Mori, MD, PhD

Postdoc Scholar - Neurology
[email protected]
Publications: 

CV2/CRMP5-antibody-related Paraneoplastic Neurologic Syndrome Associated with Gastrointestinal Stromal Tumor.

Internal medicine (Tokyo, Japan)

Fukushima H, Shibuya T, Awatsu T, Kurosawa T, Haga K, Murakami T, Serizawa N, Mori A, Hojo M, Yao T, Hattori N, Nagahara A

2021

Autoimmune Gastritis With Progression of Leukemic Non-Nodal Mantle Cell Lymphoma.

Cureus

Saito M, Morioka M, Izumiyama K, Mori A, Kondo T

2021

Association of Epstein-Barr virus with regression after withdrawal of immunosuppressive drugs and subsequent progression of iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with autoimmune diseases.

Hematological oncology

Fujimoto K, Hatanaka KC, Hatanaka Y, Kasahara I, Yamamoto S, Tsuji T, Nakata M, Takakuwa Y, Haseyama Y, Oyamada Y, Yonezumi M, Suzuki H, Sakai H, Noguchi H, Mori A, Nishihara H, Teshima T, Matsuno Y

2020

The identified clinical features of Parkinson's disease in homo-, heterozygous and digenic variants of PINK1.

Neurobiology of aging

Hayashida A, Li Y, Yoshino H, Daida K, Ikeda A, Ogaki K, Fuse A, Mori A, Takanashi M, Nakahara T, Yoritaka A, Tomizawa Y, Furukawa Y, Kanai K, Nakayama Y, Ito H, Ogino M, Hattori Y, Hattori T, Ichinose Y, Takiyama Y, Saito T, Kimura T, Aizawa H, Shoji H, Mizuno Y, Matsushita T, Sato M, Sekijima Y, Morita M, Iwasaki A, Kusaka H, Tada M, Tanaka F, Sakiyama Y, Fujimoto T, Nagara Y, Kashihara K, Todo H, Nakao K, Tsuruta K, Yoshikawa M, Hara H, Yokote H, Murase N, Nakamagoe K, Tamaoka A, Takamiya M, Morimoto N, Nokura K, Kako T, Funayama M, Nishioka K, Hattori N

2020

Identifying Therapeutic Agents for Amelioration of Mitochondrial Clearance Disorder in Neurons of Familial Parkinson Disease.

Stem cell reports

Yamaguchi A, Ishikawa KI, Inoshita T, Shiba-Fukushima K, Saiki S, Hatano T, Mori A, Oji Y, Okuzumi A, Li Y, Funayama M, Imai Y, Hattori N, Akamatsu W

2020

Lipids: Key Players That Modulate a-Synuclein Toxicity and Neurodegeneration in Parkinson's Disease.

International journal of molecular sciences

Mori A, Imai Y, Hattori N

2020

Shared Metabolic Profile of Caffeine in Parkinsonian Disorders.

Movement disorders : official journal of the Movement Disorder Society

Takeshige-Amano H, Saiki S, Fujimaki M, Ueno SI, Li Y, Hatano T, Ishikawa KI, Oji Y, Mori A, Okuzumi A, Tsunemi T, Daida K, Ishiguro Y, Imamichi Y, Nanmo H, Nojiri S, Funayama M, Hattori N

2020

Nonmercaptalbumin as an oxidative stress marker in Parkinson's and PARK2 disease.

Annals of clinical and translational neurology

Ueno SI, Hatano T, Okuzumi A, Saiki S, Oji Y, Mori A, Koinuma T, Fujimaki M, Takeshige-Amano H, Kondo A, Yoshikawa N, Nojiri T, Kurano M, Yasukawa K, Yatomi Y, Ikeda H, Hattori N

2020

Mutations in CHCHD2 cause a-synuclein aggregation.

Human molecular genetics

Ikeda A, Nishioka K, Meng H, Takanashi M, Hasegawa I, Inoshita T, Shiba-Fukushima K, Li Y, Yoshino H, Mori A, Okuzumi A, Yamaguchi A, Nonaka R, Izawa N, Ishikawa KI, Saiki H, Morita M, Hasegawa M, Hasegawa K, Elahi M, Funayama M, Okano H, Akamatsu W, Imai Y, Hattori N

2019

Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy.

PloS one

Mori A, Ishikawa KI, Saiki S, Hatano T, Oji Y, Okuzumi A, Fujimaki M, Koinuma T, Ueno SI, Imamichi Y, Hattori N

2019

Parkinson's disease-associated iPLA2-VIA/PLA2G6 regulates neuronal functions and a-synuclein stability through membrane remodeling.

Proceedings of the National Academy of Sciences of the United States of America

Mori A, Hatano T, Inoshita T, Shiba-Fukushima K, Koinuma T, Meng H, Kubo SI, Spratt S, Cui C, Yamashita C, Miki Y, Yamamoto K, Hirabayashi T, Murakami M, Takahashi Y, Shindou H, Nonaka T, Hasegawa M, Okuzumi A, Imai Y, Hattori N

2019

A metabolic profile of polyamines in parkinson disease: A promising biomarker.

Annals of neurology

Saiki S, Sasazawa Y, Fujimaki M, Kamagata K, Kaga N, Taka H, Li Y, Souma S, Hatano T, Imamichi Y, Furuya N, Mori A, Oji Y, Ueno SI, Nojiri S, Miura Y, Ueno T, Funayama M, Aoki S, Hattori N

2019

Potential Mechanisms of T Cell-Mediated and Eosinophil-Independent Bronchial Hyperresponsiveness.

International journal of molecular sciences

Saeki M, Nishimura T, Kitamura N, Hiroi T, Mori A, Kaminuma O

2019

Thrombospondin 1-mediated suppression of mast cell degranulation is involved in the efficacy of sublingual immunotherapy.

Allergology international : official journal of the Japanese Society of Allergology

Kaminuma O, Kitamura N, Gotoh M, Shindo M, Watanabe N, Saeki M, Nishimura T, Mori A, Nemoto S, Tatsumi H, Okubo K, Hiroi T

2019

Metabolomics-based identification of metabolic alterations in PARK2.

Annals of clinical and translational neurology

Okuzumi A, Hatano T, Ueno SI, Ogawa T, Saiki S, Mori A, Koinuma T, Oji Y, Ishikawa KI, Fujimaki M, Sato S, Ramamoorthy S, Mohney RP, Hattori N

2019

Serum level of soluble interleukin-2 receptor is positively correlated with metabolic tumor volume on 18 F-FDG PET/CT in newly diagnosed patients with diffuse large B-cell lymphoma.

Cancer medicine

Senjo H, Kanaya M, Izumiyama K, Minauchi K, Hirata K, Mori A, Saito M, Tanaka M, Iijima H, Tsukamoto E, Itoh K, Ota S, Morioka M, Hashimoto D, Teshima T

2019

Wilms Tumor 1 Expression at Diagnosis Correlates With Genetic Abnormalities and Polymorphism But Is Not Independently Prognostic in Acute Myelogenous Leukemia: A Hokkaido Leukemia Net Study.

Clinical lymphoma, myeloma & leukemia

Hidaka D, Onozawa M, Hashiguchi J, Miyashita N, Kasahara K, Fujisawa S, Hayase E, Okada K, Shiratori S, Goto H, Sugita J, Nakagawa M, Hashimoto D, Kahata K, Endo T, Yamamoto S, Tsutsumi Y, Haseyama Y, Nagashima T, Mori A, Ota S, Sakai H, Ishihara T, Imai K, Miyagishima T, Kakinoki Y, Kurosawa M, Kobayashi H, Iwasaki H, Shimizu C, Kondo T, Teshima T

2018

Neuromelanin imaging and midbrain volumetry in progressive supranuclear palsy and Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society

Taniguchi D, Hatano T, Kamagata K, Okuzumi A, Oji Y, Mori A, Hori M, Aoki S, Hattori N

2018

Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease.

Neurology

Fujimaki M, Saiki S, Li Y, Kaga N, Taka H, Hatano T, Ishikawa KI, Oji Y, Mori A, Okuzumi A, Koinuma T, Ueno SI, Imamichi Y, Ueno T, Miura Y, Funayama M, Hattori N

2018

Decreased long-chain acylcarnitines from insufficient ß-oxidation as potential early diagnostic markers for Parkinson's disease.

Scientific reports

Saiki S, Hatano T, Fujimaki M, Ishikawa KI, Mori A, Oji Y, Okuzumi A, Fukuhara T, Koinuma T, Imamichi Y, Nagumo M, Furuya N, Nojiri S, Amo T, Yamashiro K, Hattori N

2017

Serum uric acid level is linked to the disease progression rate in male patients with multiple system atrophy.

Clinical neurology and neurosurgery

Fukae J, Fujioka S, Yanamoto S, Mori A, Nomi T, Hatano T, Fukuhara K, Ouma S, Hattori N, Tsuboi Y

2017

Increased serum IL-17A and Th2 cytokine levels in patients with severe uncontrolled asthma.

European cytokine network

Hasegawa T, Uga H, Mori A, Kurata H

2017

Neuropathology of PARK14 is identical to idiopathic Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society

Miki Y, Yoshizawa T, Morohashi S, Seino Y, Kijima H, Shoji M, Mori A, Yamashita C, Hatano T, Hattori N, Wakabayashi K

2017

Mitochondrial-Associated Membranes in Parkinson's Disease.

Advances in experimental medicine and biology

Hattori N, Arano T, Hatano T, Mori A, Imai Y

2017

Multiple QTL Determine Dorsal Abdominal Scale Patterns in the Mosquito Aedes aegypti.

The Journal of heredity

Mori A, Tsuda Y, Takagi M, Higa Y, Severson DW

2016

Ultra-high level of serum soluble interleukin-2 receptor at diagnosis predicts poor outcome for angioimmunoblastic T-cell lymphoma.

Leukemia & lymphoma

Shiratori S, Kosugi-Kanaya M, Shigematsu A, Kobayashi H, Yamamoto S, Kobayashi N, Iwasaki H, Mori A, Kunieda Y, Yutaka T, Kurosawa M, Kakinoki Y, Endo T, Kondo T, Hashino S, Teshima T

2015

[Comparison of exhaled nitric oxide levels measured by two offline methods and the NO breath® method in Japan].

Arerugi = [Allergy]

Ito J, Tsuburai T, Atsuta R, Watai K, Fukuhara M, Hayashi H, Minami T, Tanimoto H, Oshikata C, Sekiya K, Tsurikizawa N, Fukutomi Y, Harada N, Maeda Y, Mori A, Hasegawa M, Taniguchi M, Takahashi K, Akiyama K

2014

IgE Abs to Der p 1 and Der p 2 as diagnostic markers of house dust mite allergy as defined by a bronchoprovocation test.

Allergology international : official journal of the Japanese Society of Allergology

Minami T, Fukutomi Y, Lidholm J, Yasueda H, Saito A, Sekiya K, Tsuburai T, Maeda Y, Mori A, Taniguchi M, Hasegawa M, Akiyama K

2014

Identification of a Japanese family with LRRK2 p.R1441G-related Parkinson's disease.

Neurobiology of aging

Hatano T, Funayama M, Kubo SI, Mata IF, Oji Y, Mori A, Zabetian CP, Waldherr SM, Yoshino H, Oyama G, Shimo Y, Fujimoto KI, Oshima H, Kunii Y, Yabe H, Mizuno Y, Hattori N

2014

¹8F-FDG PET/CT imaging for a gastrointestinal mantle cell lymphoma with multiple lymphomatous polyposis.

World journal of gastroenterology

Saito M, Miyazaki M, Tanino M, Tanaka S, Miyashita K, Izumiyama K, Mori A, Irie T, Tanaka M, Morioka M, Tsukamoto E

2014

Food Allergen-induced IgE Response Mouse Model Created by Injection of in vitro Differentiated Th2 Cell Culture and Oral Antigen Intake.

Bioscience of microbiota, food and health

Shibahara K, Nakajima-Adachi H, Kaminuma O, Hiroi T, Mori A, Hachimura S

2014

Motor-dominant polyneuropathy due to IgM monoclonal antibody against disialosyl gangliosides in a patient with mantle cell lymphoma.

Journal of the neurological sciences

Mori A, Ueno Y, Kuroki T, Hoshino Y, Shimura H, Sekiguchi Y, Noguchi M, Hamada Y, Kusunoki S, Hattori N, Urabe T

2013

One year long-term study on abuse liability of nalfurafine in hemodialysis patients.

International journal of clinical pharmacology and therapeutics

Ueno Y, Mori A, Yanagita T

2013

Bilateral facial nerve palsy due to otitis media associated with myeloperoxidase-antineutrophil cytoplasmic antibody.

The American journal of the medical sciences

Mori A, Hira K, Hatano T, Okuma Y, Kubo S, Hirano K, Ohno K, Noda K, Suzuki H, Ohsawa I, Hattori N

2013

Gradient echo T2*-weighted magnetic resonance imaging revealing cerebral microbleeds in a patient with microscopic polyangiitis complicated by cerebrovascular disease.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association

Yamashiro K, Mori A, Shimada Y, Furuya T, Noda K, Urabe T, Hattori N, Okuma Y

2011

Endoscopic follow-up of 3 cases with gastrointestinal tract involvement of mantle cell lymphoma.

Internal medicine (Tokyo, Japan)

Saito M, Mori A, Irie T, Tanaka M, Morioka M, Ozasa M, Kobayashi T, Saga A, Miwa K, Tanaka S

2010

Neurons associated with the flip-flop activity in the lateral accessory lobe and ventral protocerebrum of the silkworm moth brain.

The Journal of comparative neurology

Iwano M, Hill ES, Mori A, Mishima T, Mishima T, Ito K, Kanzaki R

2010

Self-sustained circadian rhythm in cultured human mononuclear cells isolated from peripheral blood.

Neuroscience research

Ebisawa T, Numazawa K, Shimada H, Izutsu H, Sasaki T, Kato N, Tokunaga K, Mori A, Honma K, Honma S, Shibata S

2009

Development of transgenic rice expressing mite antigen for a new concept of immunotherapy.

International archives of allergy and immunology

Suzuki K, Kaminuma O, Yang L, Motoi Y, Takai T, Ichikawa S, Okumura K, Ogawa H, Mori A, Takaiwa F, Hiroi T

2009

Role of multidrug resistance-associated protein 1 in the pathogenesis of allergic airway inflammation.

American journal of physiology. Lung cellular and molecular physiology

Yoshioka M, Sagara H, Takahashi F, Harada N, Nishio K, Mori A, Ushio H, Shimizu K, Okada T, Ota M, Ito YM, Nagashima O, Atsuta R, Suzuki T, Fukuda T, Fukuchi Y, Takahashi K

2008

Long-term administration of a low-molecular-weight heparin contributed to successful treatment in a patient with primary mediastinal large B-cell lymphoma and venous thromboembolism.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Mori A, Ibata M, Mashiko S, Tsutsumi Y, Masauzi N, Hashino S, Morioka M, Asaka M, Imamura M

2008

Genetic factors in the treatment of bronchial asthma.

Expert review of clinical immunology

Kaminuma O, Suko M, Mori A

2006

Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies.

Journal of the American Society of Nephrology : JASN

Wikström B, Gellert R, Ladefoged SD, Danda Y, Akai M, Ide K, Ogasawara M, Kawashima Y, Ueno K, Mori A, Ueno Y

2005

Expression of B7-H1 and B7-DC on the airway epithelium is enhanced by double-stranded RNA.

Biochemical and biophysical research communications

Tsuda M, Matsumoto K, Inoue H, Matsumura M, Nakano T, Mori A, Azuma M, Nakanishi Y

2005